GO:0071315 cellular response to morphine: Signaling Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0071315 cellular response to morphine describes any process by which a cell changes its state or activity in response to morphine, an opioid alkaloid [1,3].
Morphine triggers cell-type-specific transcriptional programs; single-cell RNA-seq of mouse brain revealed robust responses in glia, including oligodendrocytes and astrocytes.
Astrocytes are key effectors: morphine-induced conditioned responses depend on astrocytic glucocorticoid receptor signaling and lactate release.
Autophagy in dopaminergic neurons, mediated by Atg5 and Atg7, regulates cellular and behavioral responses to morphine.
Morphine modulates neuroendocrine and immune cell functions, including inhibition of the pituitary-adrenal response and enhancement of granulocyte responses [2,6].
Cellular senescence and neuroprotection are emerging themes; phoenixin-14 ameliorates morphine-induced senescence in neuronal cells.

Description

Morphine is a potent opioid alkaloid used clinically for pain management, but its cellular effects extend far beyond analgesia. The Gene Ontology term GO:0071315, cellular response to morphine, captures the diverse molecular and cellular changes that occur when a cell encounters morphine [1,3]. This term is essential for researchers investigating opioid pharmacology, addiction, neuroinflammation, and the cellular basis of tolerance and dependence. Understanding this response at the cellular level is critical because morphine acts on multiple cell types, including neurons, astrocytes, microglia, and immune cells, each with distinct signaling and transcriptional outcomes [1,3,6]. Recent advances in single-cell technologies have revealed that morphine elicits a robust and cell-type-specific transcriptional response, particularly in glial cells. Astrocytes, for example, respond to morphine by releasing lactate in a glucocorticoid receptor-dependent manner, which is required for conditioned responses to morphine. In neurons, autophagy-related proteins such as Atg5 and Atg7 modulate both cellular and behavioral responses to morphine, linking basic cellular processes to addiction-related behaviors. Morphine also affects neuroendocrine function by inhibiting the pituitary-adrenal response to corticotropin-releasing hormone and modulates immune cell activity, such as enhancing granulocyte responses. For researchers, GO:0071315 provides a framework to systematically study how morphine changes cell behavior, gene expression, and metabolism. It is relevant to neuroscience, immunology, and drug discovery, and it supports the development of CRISPR-based models to dissect causal genes and pathways. This article reviews the definition, mechanisms, key genes, disease links, and research methods for studying cellular response to morphine, with a focus on publication-ready, evidence-based insights.

cellular response to morphine At A Glance

GO ID GO:0071315
GO term cellular response to morphine
Ontology biological_process
Synonym None
Major function Cellular adaptation to morphine stimulus, including changes in gene expression, secretion, and metabolism
Definition source QuickGO
Related cell types Neurons, astrocytes, microglia, immune cells
Key signaling Glucocorticoid receptor, autophagy, neuroendocrine pathways

What Is GO:0071315?

GO:0071315 cellular response to morphine is defined as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a morphine stimulus. Morphine is an opioid alkaloid isolated from opium, with a complex ring structure. This term encompasses the immediate and long-term cellular changes triggered by morphine, including alterations in signaling pathways, gene expression, metabolism, and secretion [1,3].

Why Is cellular response to morphine Important in Cell Biology?

Cellular response to morphine is critically important because it underlies the therapeutic effects, side effects, tolerance, and addiction liability of morphine. At the cellular level, morphine triggers adaptive changes in neurons and glia that contribute to pain relief but also to dependence and neuroinflammation [1,3]. Understanding these processes is essential for developing safer analgesics and for identifying cellular targets that can modulate opioid responses. Moreover, morphine's effects on immune cells and neuroendocrine systems highlight its broad physiological impact [2,6].
Morphine is a mainstay analgesic, and cellular responses determine both efficacy and side effects.
Astrocytic responses to morphine, including lactate release, are required for conditioned responses, linking glia to addiction.
Single-cell RNA-seq shows robust glial transcriptional responses to morphine, revealing new cell-type-specific targets.
Autophagy in dopaminergic neurons regulates behavioral responses to morphine, connecting cellular stress pathways to addiction.
Morphine inhibits the pituitary-adrenal response to CRH, affecting neuroendocrine function.
Morphine enhances granulocyte responses, indicating immunomodulatory effects.
Cellular senescence in neuronal cells is a newly recognized morphine response, with potential for neuroprotection.
Understanding cellular response to morphine aids in developing CRISPR models for opioid research.
It provides a framework for studying drug-induced plasticity in diverse cell types.
It is relevant to pain management, addiction medicine, and neuroimmunology.

What Happens During cellular response to morphine?

Morphine sensing and receptor-mediated signaling
In simple terms: Morphine binds to receptors on the cell surface, triggering the first wave of cellular changes.
Morphine primarily acts through opioid receptors, but the cellular response involves downstream signaling that varies by cell type. In astrocytes, morphine-induced conditioned responses depend on glucocorticoid receptor signaling, indicating that steroid hormone pathways intersect with morphine sensing. In neurons, morphine exposure leads to changes in dopamine neuron responsiveness, as shown by adolescent cannabinoid exposure altering responses to drugs of abuse including morphine. These initial signaling events set the stage for transcriptional and metabolic changes.
Transcriptional reprogramming in glia and neurons
In simple terms: Morphine changes which genes are turned on or off in different brain cells.
Single-cell RNA-seq of mouse brain after morphine treatment revealed a robust transcriptional response, particularly in glial cells such as oligodendrocytes and astrocytes. This response includes changes in genes related to myelination, immune function, and metabolism. The cell-type-specific nature of this reprogramming highlights the importance of studying morphine responses at single-cell resolution.
Metabolic and secretory changes: lactate release from astrocytes
In simple terms: Astrocytes release lactate in response to morphine, which affects neuronal function and behavior.
Astrocytes determine conditioned response to morphine via glucocorticoid receptor-dependent regulation of lactate release. This metabolic coupling between glia and neurons is a key effector mechanism of the cellular response to morphine, linking energy metabolism to behavioral plasticity.
Autophagy and cellular stress responses
In simple terms: Morphine triggers autophagy, a cellular cleanup process, in dopaminergic neurons.
Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine. This indicates that morphine activates autophagy pathways, which in turn modulate neuronal function and addiction-related behaviors. Dysregulation of autophagy may contribute to morphine-induced neurotoxicity or tolerance.
Neuroendocrine and immune cell responses
In simple terms: Morphine affects hormone release and immune cell activity.
Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects, demonstrating a neuroendocrine component of the cellular response. Additionally, morphine enhances the granulocyte response to thioglycollate administration in rats, showing that immune cells also respond to morphine. These systemic effects are part of the broader cellular response to morphine.
Cellular senescence and neuroprotection
In simple terms: Morphine can induce senescence in neuronal cells, but this can be ameliorated.
Phoenixin-14 ameliorates cellular senescence against morphine in M17 neuronal cells, indicating that morphine can induce senescence and that protective factors can counteract it. This highlights a novel cellular outcome of morphine exposure with potential therapeutic implications.

Key Genes Involved in GO:0071315 cellular response to morphine

The following genes and proteins have been experimentally implicated in the cellular response to morphine, based on the verified literature.
GeneMajor RoleResearch Relevance
Atg5Autophagy initiationRegulates cellular and behavioral responses to morphine in dopaminergic neurons
Atg7Autophagy initiationRegulates cellular and behavioral responses to morphine in dopaminergic neurons
GR (Nr3c1)Glucocorticoid receptor signalingAstrocytic GR-dependent lactate release determines conditioned response to morphine
MCT (monocarboxylate transporters)Lactate transportMediates astrocyte-neuron lactate shuttle in morphine response
Dopamine receptorsDopaminergic signalingAdolescent cannabinoid exposure alters morphine response in midbrain dopamine neurons
CRHCorticotropin-releasing hormoneMorphine inhibits pituitary-adrenal response to CRH
ACTHAdrenocorticotropic hormonePart of neuroendocrine response to morphine
CortisolGlucocorticoid hormoneNeuroendocrine response to morphine
Granulocyte markersImmune cell activationMorphine enhances granulocyte response
Phoenixin-14NeuropeptideAmeliorates morphine-induced senescence in neuronal cells
Senescence markers (p16, p21)Cellular senescenceMorphine induces senescence in M17 cells
Oligodendrocyte genesMyelinationRobust transcriptional response to morphine in glia
Astrocyte genesGlial functionSingle-cell RNA-seq reveals astrocyte response to morphine
Microglia genesNeuroinflammationGlial transcriptional response to morphine
Lactate dehydrogenaseLactate metabolismAstrocytic lactate release in morphine response
Glucocorticoid receptor target genesStress responseMediate astrocytic response to morphine
Autophagy-related genesCellular stressModulate morphine responses

How Is cellular response to morphine Regulated?

The cellular response to morphine is regulated at multiple levels. Astrocytic glucocorticoid receptor signaling is a key regulator of lactate release and conditioned responses to morphine. Autophagy, controlled by Atg5 and Atg7, regulates both cellular and behavioral responses to morphine in dopaminergic neurons. Additionally, neuroendocrine feedback via the pituitary-adrenal axis modulates morphine effects. These regulatory mechanisms provide potential targets for therapeutic intervention.

cellular response to morphine and Human Disease

GeneDisease / BiologyPotential Experimental Model
Atg5Opioid use disorder, autophagy dysfunctionConditional KO in dopaminergic neurons
Atg7Opioid use disorder, autophagy dysfunctionConditional KO in dopaminergic neurons
NR3C1 (GR)Addiction, stress responseAstrocyte-specific KO
MCT1/MCT4Metabolic coupling in addictionKnockdown or KO in astrocytes
p16/p21Cellular senescence, neurodegenerationOverexpression in neuronal cell lines
Opioid use disorder and addiction
Cellular responses to morphine in dopaminergic neurons and glia contribute to addiction-related behaviors. Autophagy in dopaminergic neurons regulates behavioral responses to morphine, suggesting that dysregulated autophagy may be involved in opioid use disorder. Astrocytic lactate release is required for conditioned responses to morphine, linking glial metabolism to addiction.
Neuroinflammation and glial dysfunction
Morphine elicits robust transcriptional responses in glia, including astrocytes and oligodendrocytes, which may contribute to neuroinflammation and white matter changes. These glial responses are potential targets for mitigating morphine-induced neurotoxicity.
Neuroendocrine disorders
Morphine inhibits the pituitary-adrenal response to CRH, which can lead to endocrine abnormalities such as adrenal insufficiency. This highlights the clinical importance of cellular responses to morphine in the endocrine system.
Cellular senescence and neurodegeneration
Morphine induces cellular senescence in neuronal cells, which can be ameliorated by phoenixin-14. This suggests that morphine may accelerate neuronal aging and that senolytic or protective strategies could be beneficial.

From cellular response to morphine-Related Genes to Experimental Models

Research QuestionSuitable Model
Does Atg5 in dopaminergic neurons regulate morphine reward?Conditional Atg5 KO mice
Is astrocytic GR required for morphine conditioned response?Astrocyte-specific GR KO mice
What is the transcriptional response to morphine in glia?Single-cell RNA-seq of mouse brain
Does morphine induce senescence in neurons?M17 neuronal cell line with senescence markers
How does morphine affect granulocyte function?Rat granulocyte assays
Does morphine inhibit pituitary-adrenal axis?Human subjects with CRH stimulation

How to Study the cellular response to morphine Process

MethodWhat It MeasuresTypical Application
Single-cell RNA-seqCell-type-specific gene expressionGlial response to morphine
Conditional knockoutGene function in specific cell typesAtg5/Atg7 in dopaminergic neurons
Behavioral assaysReward, dependence, conditioned responseMorphine conditioned place preference [1,7]
Hormone assaysNeuroendocrine functionCRH stimulation test
Senescence assaysCellular aging markersMorphine-induced senescence
Granulocyte function assaysImmune cell activityMorphine effects on granulocytes
Lactate measurementsMetabolic fluxAstrocyte-neuron lactate shuttle
Single-cell RNA sequencing
Single-cell RNA-seq has been used to uncover the robust transcriptional response to morphine by glia, revealing cell-type-specific gene expression changes. This method is ideal for dissecting heterogeneous cellular responses in the brain.
Behavioral assays combined with genetic manipulation
Conditioned place preference and other behavioral assays, combined with conditional knockout of autophagy genes, have been used to link cellular responses to morphine with behavioral outcomes. Astrocyte-specific manipulations have also been used to study conditioned responses.
Neuroendocrine challenge tests
In human subjects, morphine inhibition of the pituitary-adrenal response to CRH has been assessed using hormone measurements. This method is valuable for studying the endocrine component of morphine response.
Cellular senescence assays
Senescence-associated beta-galactosidase staining and marker expression have been used to detect morphine-induced senescence in M17 neuronal cells. This approach can be adapted for high-throughput screening of protective compounds.

How CRISPR Can Be Used to Study GO:0071315 cellular response to morphine

Knockout

CRISPR knockout of genes such as Atg5 or Atg7 in dopaminergic neurons can be used to study their role in morphine responses, as demonstrated by conditional knockout studies. Knockout of glucocorticoid receptor in astrocytes can test its requirement for morphine-induced lactate release.

Point Mutation

Point mutations can be introduced to mimic or disrupt phosphorylation sites or other regulatory residues in genes involved in morphine response, such as autophagy proteins or receptors. This allows precise dissection of signaling mechanisms.

Knock-in

Knock-in of reporter genes or tags (e.g., GFP) into endogenous loci can visualize the expression and localization of key proteins during morphine response. For example, tagging Atg5 or GR can reveal their dynamics in live cells.

Overexpression

Overexpression of protective factors such as phoenixin-14 or anti-senescence genes can be achieved via CRISPR activation or lentiviral delivery to study their ability to ameliorate morphine-induced cellular changes.

How EDITGENE Supports cellular response to morphine Research

Researchers studying cellular response to morphine-related genes often need to determine whether a candidate gene is causally involved in morphine-induced cellular changes. CRISPR-based models provide a robust way to test causality by manipulating genes in relevant cell types, such as neurons, astrocytes, and immune cells. EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for cellular response to morphine research.

Frequently Asked Questions About cellular response to morphine

GO:0071315 is a Gene Ontology biological process term describing any cellular change in state or activity in response to morphine, an opioid alkaloid [1,3].
Key genes include Atg5, Atg7, NR3C1 (glucocorticoid receptor), and genes related to dopamine signaling and senescence [1,7,8].
Morphine induces astrocytes to release lactate via glucocorticoid receptor signaling, which is required for conditioned responses.
Yes, morphine activates Atg5- and Atg7-dependent autophagy in dopaminergic neurons, which regulates behavioral responses.
Single-cell RNA-seq shows robust transcriptional responses to morphine in glia, including astrocytes and oligodendrocytes.
Morphine can induce senescence in M17 neuronal cells, which can be ameliorated by phoenixin-14.
Morphine enhances granulocyte responses in rats, indicating immunomodulatory effects.
Morphine inhibits the pituitary-adrenal response to CRH in normal subjects.
Methods include single-cell RNA-seq, conditional knockout, behavioral assays, hormone assays, and senescence assays [1,2,3,7,8].
CRISPR knockout, point mutation, knock-in, and overexpression models can test causal roles of genes in morphine responses [1,7,8].

Conclusion

GO:0071315 cellular response to morphine encompasses a complex array of cellular changes triggered by morphine, involving neurons, glia, and immune cells. Key mechanisms include glucocorticoid receptor-dependent lactate release from astrocytes, autophagy in dopaminergic neurons, and neuroendocrine modulation [1,2,7]. These processes are relevant to addiction, neuroinflammation, and endocrine disorders. CRISPR-based models offer powerful tools to dissect causal genes and pathways, and EDITGENE provides comprehensive services to support such research.

References

  1. 1. Skupio U et al.. 2020. Astrocytes determine conditioned response to morphine via glucocorticoid receptor-dependent regulation of lactate release.. Neuropsychopharmacology 45(2):404-415 PMID: 31254970
  2. 2. Rittmaster RS et al.. 1985. Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects.. J Clin Endocrinol Metab 60(5):891-5 PMID: 2984235
  3. 3. Avey D et al.. 2018. Single-Cell RNA-Seq Uncovers a Robust Transcriptional Response to Morphine by Glia.. Cell Rep 24(13):3619-3629.e4 PMID: 30257220
  4. 5. Pistis M et al.. 2004. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.. Biol Psychiatry 56(2):86-94 PMID: 15231440
  5. 6. Fecho K et al.. 2002. Morphine-induced enhancement in the granulocyte response to thioglycollate administration in the rat.. Inflammation 26(6):259-71 PMID: 12546135
  6. 7. Su LY et al.. 2017. Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine.. Autophagy 13(9):1496-1511 PMID: 28722508
  7. 8. Hu Y et al.. 2022. Phoenixin-14 Ameliorates Cellular Senescence Against Morphine in M17 Neuronal Cells.. Neurotox Res 40(2):498-507 PMID: 35298792
Contact Us
*
*
*
*
How did you hear about us: